OBN is governed by a balanced Board of Directors, whose members bring to the organisation significant commercial experience at the highest level across the pharma, biotech, medtech and financial sectors. The Company believes that the skills and experience of the Directors are of an appropriate mix to provide effective governance and management of the business.
The Board is responsible for the organisation’s system of corporate governance and internal control and is accountable for all its activities. The Board reviews the operational performance of the organisation on a regular basis and aims to represent the interests of OBN’s Members through setting and reviewing its strategic focus, as well as to ensure the growth and development of a successful and sustainable organisation.
The Board members are listed below.